RIS Rx names John Driscoll as board chairman

RIS Rx, a Newport Beach-based healthcare technology company, appointed John Driscoll as Chairman of the Board of Directors, the company announced.

Driscoll brings extensive healthcare industry experience, having most recently served as Executive Vice President and President, U.S. Healthcare at Walgreens Boots Alliance following its acquisition of CareCentrix. He led CareCentrix as CEO for nearly a decade, focusing on care-at-home capabilities and post-acute care services.

His career includes leadership roles at Castlight Health, Medco as Group President, and founding the Surescripts e-prescribing network. Driscoll currently serves as Independent Chairman of the Board at Waystar (NASDAQ: WAY), a healthcare payment software provider, and chairs the boards of UConn Health and Magnit Global.

"RIS Rx was born out of the need for transparency, accountability, and clinical rigor in how pharmaceutical manufacturers address leakage," said Gerard Rivera, CEO and Co-Founder of RIS Rx. "With John as Chairman, we gain not only a seasoned leader but a deeply trusted advisor."

RIS Rx focuses on helping pharmaceutical manufacturers optimize patient payment revenue cycles through proprietary software and pharmacist-led services. The company was founded in 2020 and serves pharmaceutical manufacturers across multiple drug brands.

"The team has built an innovative technology platform that tackles one of the industry's most persistent challenges: ensuring that financial support truly reaches patients," Driscoll said.

The appointment comes as RIS Rx aims to expand its operations in the pharmaceutical payment management sector, according to the company's press release statement.

You May Also Be Interested In

• Space-Eyes names four directors ahead of planned Nasdaq listing
• Solowin Holdings marks 10 years, expands into stablecoins and AI
• Two Harbors receives final approval for CrossCountry Mortgage merger